Evolus, Inc. (EOLS) Financial Statements
Evolus, Inc. (EOLS) reported trailing twelve-month revenue of $316.5M (up 13.9% year on year) and net income of -$34.3M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$21.9M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
EOLSEvolus, Inc.Follow EOLS — free
—
Price chart with a free account
- Market cap
- 463.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 10 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 34.9 | 56.5 | 99.7 | 148.6 | 202.1 | 266.3 | 297.2 | 316.5 | |
| Gross profit | 26.9 | 38.2 | 56.1 | 89.8 | 137.6 | 182.3 | 197.1 | 211.2 | |
| Research & development | 4.0 | 1.7 | 2.1 | 4.7 | 6.6 | 9.2 | 9.6 | 9.7 | |
| Operating income | -98.9 | -153.1 | -44.4 | -65.3 | -49.2 | -34.4 | -32.7 | -18.7 | |
| Pre-tax income | -105.1 | -162.9 | -46.8 | -74.3 | -61.5 | -49.8 | -51.0 | -33.7 | |
| Income tax | -15.0 | 0.1 | 0.0 | 0.1 | 0.2 | 0.7 | 0.7 | 0.7 | |
| Net income | -90.0 | -163.0 | -46.8 | -74.4 | -61.7 | -50.4 | -51.6 | -34.3 | |
| Diluted EPS ($) | -3.19 | -4.83 | -0.94 | -1.33 | -1.08 | -0.81 | -0.80 | -0.52 | |
| Diluted shares (mn) | — | — | 49.8 | 56.1 | 56.9 | 62.0 | 64.5 | — |
USD millions · SEC XBRL
Evolus, Inc. — questions
- What is Evolus, Inc.'s revenue?
- $316.5M over the twelve months to 2026-06-30, up 13.9% year on year, from its 10-Q and 10-K filings.
- What is Evolus, Inc.'s net income?
- -$34.3M over the twelve months to 2026-06-30.
- What is Evolus, Inc.'s free cash flow?
- -$21.9M over the twelve months to 2026-06-30.
- What are Evolus, Inc.'s diluted earnings per share?
- $-0.52 over the twelve months to 2026-06-30.
Every figure on this page comes from Evolus, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.